Scientists are reporting development of an advanced lithium-ion battery that is ideal for powering the electric vehicles now making their way into dealer showrooms. The new battery can store large amounts of energy in a small space and has a high rate capacity, meaning it can provide current even in extreme temperatures.
Researchers have developed a simple method of making short protein chains with spiral structures that can also dissolve in water, two desirable traits not often found together. Such structures could have applications as building blocks for self-assembling nanostructures and as agents for drug and gene delivery.
The Pittcon 2011 Exposition, which takes place March 14 - 17, at the Georgia World Congress Center, Atlanta, Georgia, will include 978 exhibitors (count as of February 15) that provide products, services, and support for all facets of laboratory operations in the industrial, academic, and government sectors.
Ultrasensitive electronic skin developed by Stanford researcher Zhenan Bao is getting even better. Now she's demonstrated that it can detect chemicals and biological molecules, in addition to sensing an incredibly light touch. And it can now be powered by a new, stretchable solar cell she's developed in her lab, opening up more applications in clothing, robots, prosthetic limbs and more.
The Institute of Nanotechnology (IoN) has just returned from a successful mission to Nanotech 2011 in Tokyo. Together with the Nanotechnology KTN, IoN took key UK SMEs to Japan last week as part of International NanoMicroClub (INMC) initiative.
In an advance that could improve battlefield and trauma care, scientists at Albert Einstein College of Medicine of Yeshiva University have used tiny particles called nanoparticles to improve survival after life-threatening blood loss.
Researchers from Purdue University has reproduced portions of the female breast in a tiny slide-sized model dubbed "breast on-a-chip" that will be used to test nanoparticle-based approaches for the detection and treatment of breast cancer. The model mimics the branching mammary duct system, where most breast cancers begin, and will serve as an "engineered organ" to study the use of nanoparticles to detect and target tumor cells within the ducts.
By replacing a chemical group in the macromolecule, researchers have found a way to bypass RNase and create stable three-dimensional configurations of RNA, greatly expanding the possibilities for RNA in nanotechnology.
Rice University bioengineers and physician-scientists at Baylor College of Medicine and Texas Children's Hospital have successfully destroyed tumors of human brain cancer cells in the first animal tests of a minimally invasive treatment that zaps glioma tumors with heat. The tests involved nanoshells, light-activated nanoparticles that are designed to destroy tumors with heat and avoid the unwanted side effects of drug and radiation therapies.
A paper published recently in the journal Nanomedicine could provide the foundation for a new ovarian cancer treatment option, one that would use an outside-the-body filtration device to remove a large portion of the free-floating cancer cells that often create secondary tumors.
Driven by scientific progress and economic stimulus, medical diagnostics will move to a stage in which straightforward medical diagnoses are independent of physician visits and large centralized laboratories. The future of basic diagnostic medicine will lie in the hands of private individuals. Researchers have taken significant strides towards achieving this goal by developing an autoassembly assay for disease biomarker detection which obviates the need for washing steps and is run on a handheld sensing platform.
A large team of researchers from the Massachusetts Institute of Technology, Massachusetts General Hospital, and Harvard Medical School have developed multilayered, or multistage, nanoparticles that partially dissolve once they accumulate around tumors, leaving behind a payload of nanoparticles a mere one-tenth the size of the original delivery vehicle.
Researchers at the Massachusetts Institute of Technology (MIT) and Brigham and Women's Hospital have shown that they can deliver the cancer drug cisplatin much more effectively and safely in a form that has been encapsulated in a nanoparticle targeted to prostate tumor cells.
Researchers at Northwestern University's Institute for Catalysis in Energy Processing have discovered a new strategy for fabricating metal nanoparticles in catalysts that promises to enhance the selectivity and yield for a wide range of structure-sensitive catalytic reactions.